MEBIAS DISCOVERY, INC.

Profile

Company Names

MEBIAS DISCOVERY, INC.

Addresses

3675 MARKET STREET, SUITE 200, PHILADELPHIA, PA 19104

Phone Numbers

267-218-0854

 

Entity Type:

CORPORATION

Industry:

PHARMACEUTICALS

Year Incorporated:

2015

State Incorporated:

DELAWARE

Total Amount Raised:

$3,623,887.00

Number of Funding Rounds:

2
Investment Rounds
Round #
Round Open Date
Amount Raised
Total Round Size
Amount Remaining to be Raised
Securities
2
2022-09-15 
$630,682.00 
$2,046,682.00 
$1,416,000.00 
Equity 
1
2019-06-27 
$2,993,205.00 
$5,743,205.00 
$2,750,000.00 
Equity 
People
First Name
Middle Name
Last Name
Titles
Related Companies
SHARIFF 
S. 
BAYOUMY 
EXECUTIVE OFFICER
MEBIAS DISCOVERY, INC.
GUANGHUI 
 
HU 
DIRECTOR
MEBIAS DISCOVERY, INC.
LAWRENCE 
C. 
KUO 
EXECUTIVE OFFICER
MEBIAS DISCOVERY, INC.
BARBARA 
 
SCHILBERG 
DIRECTOR
ONEHEALTHCOMPANY, INC.   |  ENB THERAPEUTICS, INC.   |  KERITON, INC.   |  MEBIAS DISCOVERY, INC.
MICHAEL 
 
SERRANO-WU 
DIRECTOR
RIPARIAN PHARMACEUTICALS, INC.   |  MEBIAS DISCOVERY, INC.   |  SISU PHARMA, INC.
BRETT 
A. 
TOUNGE 
EXECUTIVE OFFICER, DIRECTOR
MEBIAS DISCOVERY, INC.
Filings
Filing Date
Filing Type
Source URL
Industry Classifier
Detailed Industry
Revenue Range
Securities
First Sale Date
2022-09-23
D
Link
PHARMACEUTICALS 
 
DECLINE TO DISCLOSE 
Equity 
2022-09-15 
2019-07-11
D
Link
PHARMACEUTICALS 
 
DECLINE TO DISCLOSE 
Equity 
2019-06-27 
Brokers
Broker Dealer
Broker CRD#
Recipient Name
Recipient CRD#